Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 14 de 14
Filtrar
1.
Aliment Pharmacol Ther ; 14(3): 359-66, 2000 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10735931

RESUMEN

BACKGROUND: Although diabetic patients often have gastrointestinal complications, the gastric mucosal function in diabetes has not been well documented. AIM: To investigate the effect of fasting on the gastric mucosa in C57BL/KsJ-db +/+ db (db/db) mice, genetically non-insulin-dependent diabetic animals. METHODS: Blood glucose levels, gastric mucosal morphology, and the amount of gastric mucin were examined before and after 18 h of fasting with free access to water in db/db mice and their non-diabetic littermates (db/m). RESULTS: Although 18 h of fasting reduced the blood glucose levels of both db/db and db/m mice, fasting decreased the amount of gastric adherent mucin and caused haemorrhagic gastric lesions only in db/db mice. After fasting, oral administration of ethanol induced much more severe gastric damage in db/db than in db/m mice. The above fasting-induced gastric damage such as haemorrhagic lesions, loss of the mucin, and the increased sensitivity to ethanol worsened as the duration of diabetes became longer. Glucose ingestion in drinking water during the fasting counteracted the fall in blood glucose and prevented the decrease in the amount of gastric mucin and the formation of gastric mucosal lesions in db/db mice. CONCLUSION: These findings indicate that fasting-induced glucose deficit causes gastric mucosal lesions and increases the susceptibility of gastric mucosa to noxious agents owing to the loss of mucus glycoprotein in db/db mice. Prolonged diabetes is likely to augment the severity of fasting-induced impairment of the gastric mucosal function.


Asunto(s)
Diabetes Mellitus Experimental/patología , Diabetes Mellitus Tipo 2/patología , Ayuno/efectos adversos , Mucosa Gástrica/patología , Envejecimiento , Animales , Glucemia/metabolismo , Temperatura Corporal/fisiología , Diabetes Mellitus Experimental/metabolismo , Diabetes Mellitus Tipo 2/metabolismo , Femenino , Mucosa Gástrica/metabolismo , Masculino , Ratones , Ratones Endogámicos C57BL , Mucinas/metabolismo , Factores de Tiempo
2.
Exp Anim ; 47(1): 11-21, 1998 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-9498108

RESUMEN

In 1991, several hairless offspring were found in our black haired KK (KK-C) mouse colony. This mutant, provisionally naming KK-rhino mouse was clinicopathologically and histopathologically investigated in a chronological manner. KK-rhino has a hairless trait and wrinkled and pimpled skin, which resemble the characteristics of the so-called rhino mouse. It was presumed from a preliminary mating examination that the trait of the KK-rhino mutant might be manifested by the [hrrh] gene. Other properties of this mutant might be inherited from the maternal KK-C line. KK-rhino mouse is a unique mouse strain which has two quite different traits, "rhino" and "diabetes".


Asunto(s)
Ratones Mutantes , Animales , Recuento de Células Sanguíneas , Análisis Químico de la Sangre , Peso Corporal/genética , Cruzamiento , Femenino , Longevidad , Masculino , Ratones , Ratones Pelados , Ratones Endogámicos ICR , Ratones Mutantes/anatomía & histología , Ratones Mutantes/sangre , Ratones Mutantes/genética , Ratones Mutantes/fisiología
3.
Exp Toxicol Pathol ; 49(3-4): 295-9, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9314067

RESUMEN

Morphological examinations were carried out on hepatocyte nuclei of streptozotocin (SZ)-induced diabetic mice. The area of hepatocyte nuclei in diabetic mice was about two times larger than that in control mice, and the incidence of hepatocytes with intranuclear inclusions was 3.4 +/- 0.2% in diabetic mice and 0% in control mice, respectively. Although the incidence of binuclear hepatocytes was not significantly different between diabetic (14.5 +/- 4.6%) and control mice (16.4 +/- 4.4%), the morphology of the nuclei of binuclear hepatocytes was apparently different between diabetic and control mice. Namely, the nuclei of binuclear hepatocytes of control mice were round and identical in ultrastructural appearance, and they did not differ from those of mononuclear diploid hepatocytes. On the other hand, the nuclei of binuclear hepatocytes of diabetic mice were not identical in distribution pattern of chromatin granules, and they frequently varied in size and showed irregular contours.


Asunto(s)
Núcleo Celular/ultraestructura , Diabetes Mellitus Experimental/patología , Hígado/ultraestructura , Animales , Glucemia/metabolismo , Peso Corporal , Hipertrofia , Masculino , Ratones , Ratones Endogámicos ICR , Microscopía Electrónica , Tamaño de los Órganos
4.
Exp Toxicol Pathol ; 46(4-5): 368-74, 1994 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7894249

RESUMEN

Hepatic changes of mice in the subacute phase of streptozotocin (SZ)-induced diabetes were investigated biochemically and pathologically. Biochemically, the contents of serum glucose and of serum and liver lipids increased while the content of liver glycogen decreased in SZ-induced diabetic mice. Histopathologically, hypertrophy of hepatocytes due to an increase in number of intracytoplasmic acidophilic granules was common to SZ-induced diabetic mice. Electron microscopically, these hepatocytes were characterized by a prominent increase in number of mitochondria showing normal structure, a marked decrease of glycogen granules and poorly developed rough endoplasmic reticulum, which were common to so-called oncocytic cells. In some SZ-induced diabetic mice, bile duct hyperplasia with an appearance of cytomegalic hepatocytes was also observed.


Asunto(s)
Diabetes Mellitus Experimental/patología , Hígado/efectos de los fármacos , Hígado/patología , Estreptozocina/toxicidad , Animales , Glucemia/análisis , Diabetes Mellitus Experimental/complicaciones , Retículo Endoplásmico/efectos de los fármacos , Glucógeno/análisis , Hipertrofia/patología , Lípidos/análisis , Hígado/química , Masculino , Ratones , Ratones Endogámicos ICR , Microscopía Electrónica , Tamaño de los Órganos/efectos de los fármacos , Aumento de Peso/efectos de los fármacos
5.
J Vet Med Sci ; 54(6): 1085-90, 1992 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-1477158

RESUMEN

Experimental diabetes was induced in both control and unilaterally nephrectomized male mice by injecting streptozotocin (SZ) (50 mg/kg x 5 days) one week after nephrectomy. The time course changes in the glomerular lesions were examined for up to 12 weeks after completion of the SZ-injection (12WAI). In unilateral nephrectomized and diabetic mice, mild segmental expansion of the mesangial area developed at 4WAI, and it progressed to prominent segmental glomerulosclerosis at 12WAI. In the electron microscopic examination at 12WAI, marked expansion of the mesangial area, segmental thickening of the glomerular basement membrane, fusion of the foot processes of podocytes and a prominent increase in the number of microvilli of capillary endothelial cells were observed. On the other hand, mild to moderate expansion of the glomerular mesangial area was only sporadically found in unnephrectomized diabetic mice at 12WAI. Interestingly, Bowman's capsules of diabetic mice were generally lined with flattened epithelia but those of non-diabetic mice with cuboidal or low columnar epithelia.


Asunto(s)
Diabetes Mellitus Experimental/patología , Nefropatías Diabéticas/patología , Glomérulos Renales/patología , Animales , Glucemia/análisis , Peso Corporal , Ingestión de Líquidos , Ingestión de Alimentos , Masculino , Ratones , Ratones Endogámicos ICR , Microscopía , Microscopía Electrónica/veterinaria , Nefrectomía , Tamaño de los Órganos , Estreptozocina
6.
Inflammopharmacology ; 15(2): 90-4, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17450449

RESUMEN

We investigated the effect of ecabet sodium (ecabet) on rat acute esophageal lesions induced by reflux of gastric juice. Ligation of both pylorus and fore-stomach induced the reflux of gastric juice, decreased the amount of mucus and formed hemorrhagic lesions in the esophageal mucosa. Intragastric injection of ecabet reduced the pepsin activity and prevented both the decrease of mucus amount and formation of lesions. Ecabet enhanced the reduction in lesion formation induced by omeprazole and ranitidine without a change in decreased acid concentration and pepsin activity. Digestion of mucosa and the reduction in mucus were prevented by ecabet in the everted HCl and pepsin treated esophageal sac. These results indicate that ecabet prevents esophageal lesions by inhibiting pepsin activity as well as by protecting mucus from degradation. These further implicate the therapeutic potential of ecabet for prevention/treatment of GERD, especially in combination with a proton pump inhibitor or H(2)-antagonist.


Asunto(s)
Abietanos/farmacología , Antiulcerosos/farmacología , Enfermedades del Esófago/prevención & control , Esófago/efectos de los fármacos , Jugo Gástrico/efectos de los fármacos , Abietanos/administración & dosificación , Animales , Antiulcerosos/administración & dosificación , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Quimioterapia Combinada , Enfermedades del Esófago/etiología , Esófago/patología , Reflujo Gastroesofágico/complicaciones , Masculino , Membrana Mucosa/efectos de los fármacos , Membrana Mucosa/patología , Omeprazol/farmacología , Pepsina A/efectos de los fármacos , Pepsina A/metabolismo , Ranitidina/farmacología , Ratas , Ratas Sprague-Dawley
7.
J Pharmacol Exp Ther ; 275(1): 494-501, 1995 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-7562591

RESUMEN

We determined the mechanism of the gastroprotective effects of ecabet sodium (ecabet), a new antiulcer drug. Ecabet (12.5-100 mg/kg p.o.) dose-dependently protected gastric mucosa from ethanol-induced injuries in rats, as determined with the use of both macroscopic and microscopic analyses. Both inhibition of prostaglandin (PG) formation by indomethacin (5 mg/kg s.c.) and functional ablation of capsaicin-sensitive sensory nerves (CPSN) by systemic administration of capsaicin (125 mg/kg s.c.) partly reduced the gastroprotective activity of ecabet (25 and 100 mg/kg p.o.). Ecabet increased rat gastric mucosal PGE2 formation. The treatment with indomethacin but not capsaicin decreased the ecabet-induced increase in PGE2 formation. Inhibition of nitric oxide (NO) formation by NG-monomethyl-L-arginine (L-NMMA; 100 mg/kg i.v.) partly reversed the gastroprotective effect of ecabet and completely reversed that of capsaicin at an oral dose of 0.5 mg/kg, respectively. The effect of L-NMMA was abolished by pretreatment with L-arginine (100 mg/kg i.v.) but not with D-arginine (100 mg/kg i.v.). The gastroprotective activity of ecabet (25 mg/kg p.o.) was fully reversed by pretreatment with indomethacin in combination with L-NMMA or CPSN ablation. On the contrary, a combination of L-NMMA and CPSN ablation did not have additional effect on the suppression by either treatment alone. These findings indicate that the gastroprotection by ecabet is cooperatively mediated by endogenous PGs and CPSN-related endogenous NO.


Asunto(s)
Abietanos , Antiulcerosos/farmacología , Capsaicina/farmacología , Diterpenos/farmacología , Mucosa Gástrica/efectos de los fármacos , Mucosa Intestinal/efectos de los fármacos , Neuronas Aferentes/fisiología , Óxido Nítrico/fisiología , Prostaglandinas/fisiología , 16,16-Dimetilprostaglandina E2/farmacología , Animales , Antiinflamatorios no Esteroideos/farmacología , Arginina/análogos & derivados , Arginina/farmacología , Dinoprostona/biosíntesis , Interacciones Farmacológicas , Etanol/farmacología , Mucosa Gástrica/inervación , Mucosa Gástrica/metabolismo , Indometacina/farmacología , Mucosa Intestinal/inervación , Mucosa Intestinal/metabolismo , Masculino , Neuronas Aferentes/efectos de los fármacos , Prostaglandinas/biosíntesis , Ratas , Ratas Sprague-Dawley , Sensibilidad y Especificidad , omega-N-Metilarginina
8.
Jpn J Pharmacol ; 84(1): 51-5, 2000 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-11043453

RESUMEN

Fasting causes gastric mucosal damage in streptozotocin (STZ)-induced diabetic rats, but its pathogenic mechanism remains to be elucidated. The aim of the present study was to investigate the alteration of gastric mucosal mucin, one of the gastric defensive factors against the development of such damage. Diabetes was induced in rats by intravenous injection of STZ (65 mg/kg). The experiments were performed using 4-week STZ-diabetic rats with blood glucose levels above 350 mg/dl. The amount of gastric mucus glycoprotein was determined by gel filtration, and the distribution of neutral and acidic mucins in the stomach epithelium was examined by histochemical analysis. In normal rats, 24-h fasting neither affected the gastric mucin content nor caused any macroscopic gastric mucosal injury. In contrast, starvation significantly reduced the amount of total gastric mucus glycoprotein prior to the formation of mucosal lesions in the STZ-diabetic rats. Nine hours after food deprivation, the gastric damage developed in about 70% of the diabetic rats, the amount of mucus glycoprotein markedly decreased, and both the neutral and acidic mucins diminished in the epithelium. Taken together, in STZ-diabetic rats, fasting by itself depletes gastric mucus glycoprotein, and this depletion may be involved in the pathogenic mechanism of the formation of gastric mucosal lesions.


Asunto(s)
Diabetes Mellitus Experimental/metabolismo , Privación de Alimentos/fisiología , Glicoproteínas/metabolismo , Análisis de Varianza , Animales , Diabetes Mellitus Experimental/inducido químicamente , Diabetes Mellitus Experimental/patología , Mucosa Gástrica/patología , Masculino , Ratas , Ratas Sprague-Dawley , Estreptozocina
9.
Int J Exp Pathol ; 76(3): 171-8, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7547427

RESUMEN

Strain differences in the vulnerability of hippocampal neurons to an ischaemic insult were investigated in Sprague-Dawley, Wistar and Fischer 344 rats. Transient global brain ischaemia was produced for 5 minutes by a combination of bilateral carotid artery occlusion and oligaemic hypotension (40 mmHg) induced by exsanguination. The number of viable neurons in the CA1 subfield was counted under a light microscope 7 days after the ischaemic insult. The density of viable neurons in the CA1 subfield of normal rats was around 150 cells/mm of CA1 length in all the strains examined; after global brain ischaemia, this parameter in Sprague-Dawley, Wistar and Fischer 344 strain rats was approximately 110, 120, and 70, respectively. The results suggest that the hippocampal CA1 neurons of Fischer 344 strain rats are more vulnerable to ischaemic insult than those of the other strains. There were many F344 rats (8/21) which showed atypical vasculature patterns in the posterior region of the circle of Willis, suggesting less blood flow through anastomosis from basilar artery to posterior cerebral artery and/or ill-balanced blood flow between left and right hemispheres. These anatomical variations in the circle of Willis may in part contribute to the strain differences in the vulnerability to cerebral ischaemia.


Asunto(s)
Modelos Animales de Enfermedad , Hipocampo/patología , Ataque Isquémico Transitorio/patología , Neuronas/patología , Animales , Presión Sanguínea , Círculo Arterial Cerebral/patología , Susceptibilidad a Enfermedades , Masculino , Ratas , Ratas Endogámicas F344 , Ratas Sprague-Dawley , Ratas Wistar , Especificidad de la Especie
10.
Digestion ; 62(2-3): 116-25, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11025359

RESUMEN

BACKGROUND: The antiulcer drug ecabet 2Na (12-sulfodehydroabietic acid disodium salt) exhibits a gastroprotective activity, mainly through a local action, involving endogenous prostaglandins (PGs) and nitric oxide (NO). In the present study, we examined the effect of ecabet on the epithelial restitution of the bullfrog gastric mucosa in vitro following injury by hypertonic NaCl. METHODS: Bullfrog fundic mucosa was mounted in an Ussing chamber. The tissue injury was induced by exposure of the mucosa to 1.25 M NaCl for 5 min, and transmucosal potential difference (PD) and electrical resistance (R) were measured during a 4-hour test period. Ecabet (3-30 mg/ml) was added to the luminal solution for 10 min before or after NaCl, while 16,16-dimethyl PGE(2) (dmPGE(2): 1x 10(-6) M) or NOR-3 (a NO donor: 1 x 10(-4) M) was added to the nutrient solution 10 min before NaCl. RESULTS: Mucosal application of 1.25 M NaCl caused an immediate reduction of PD and R, followed by a gradual normalization, reaching about 70% of the pre-exposure levels within 4 h. Ecabet, added before NaCl, significantly expedited the recovery of PD and R in a concentration-dependent manner; this effect was mimicked by posttreatment with ecabet and significantly mitigated by prior addition of indomethacin (1 x 10(-5) M) or N(G)-nitro-L-arginine methyl ester (L-NAME: 1 x 10(-3) M). The epithelial restitution was also significantly promoted by serosal application of either dmPGE(2) or NOR-3. The mucosal exposure to ecabet significantly increased the luminal release of PGE(2) and NO metabolites, the effects being attenuated by indomethacin and L-NAME, respectively. The mucous secretion was increased by ecabet as well as dmPGE(2) and NOR-3, and the effect of ecabet was significantly suppressed by both indomethacin and L-NAME. The inhibitory effects of L-NAME on the ecabet action were all significantly antagonized by concurrent addition of L-arginine. CONCLUSION: These results suggest that ecabet significantly expedited the restitution following gastric surface cell injury, and this action is mediated by endogenous NO as well as PGs and may be functionally associated with an increase of mucous secretion.


Asunto(s)
Abietanos , Antiulcerosos/farmacología , Diterpenos/farmacología , Mucosa Gástrica/patología , Animales , Electrofisiología , Mucosa Gástrica/efectos de los fármacos , Mucosa Gástrica/fisiología , Moco/metabolismo , Óxido Nítrico/farmacología , Prostaglandinas/metabolismo , Prostaglandinas/farmacología , Rana catesbeiana/fisiología , Solución Salina Hipertónica/administración & dosificación , Solución Salina Hipertónica/efectos adversos
11.
Am J Physiol ; 277(4): G796-800, 1999 10.
Artículo en Inglés | MEDLINE | ID: mdl-10516145

RESUMEN

The mucosal defensive mechanisms of the esophagus against acid and pepsin remain to be elucidated. In the present study, we investigated the contribution of the salivary mucin in maintaining the integrity of the esophageal mucosa. When an everted esophageal sac, isolated from normal rat, was treated with N-acetyl-L-cysteine, a mucolytic agent, the amount of glycoprotein in the gel layer adherent to the epithelium was completely depleted and the susceptibility of the mucosa against acidified pepsin-induced digestion increased. In sialoadenectomized rats, 7 days after extirpation, the amount of glycoprotein adherent to the esophageal epithelium was definitely reduced, and the esophageal mucosa was significantly vulnerable to acidified pepsin-induced digestion compared with the sham-operated rats. Induction of regurgitation of the gastric juices into the esophagus resulted in the development of severe hemorrhagic esophageal lesions only in the sialoadenectomized rats but not in the sham-operated rats. In conclusion, the glycoprotein in the adherent gel layer in rat esophagus, which mainly derives from salivary glands, plays an important role in the preepithelial defense to maintain the integrity of the esophageal mucosa against acid and pepsin.


Asunto(s)
Enfermedades del Esófago/inducido químicamente , Enfermedades del Esófago/prevención & control , Esófago/fisiología , Mucinas/fisiología , Glándulas Salivales/metabolismo , Acetilcisteína/farmacología , Ácidos , Animales , Factor de Crecimiento Epidérmico/farmacología , Masculino , Membrana Mucosa/fisiología , Pepsina A/antagonistas & inhibidores , Ratas , Ratas Sprague-Dawley , Glándulas Salivales/fisiología
12.
Jpn J Pharmacol ; 73(2): 105-12, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9074944

RESUMEN

Effects of a new cholecystokinin (CCK)A-receptor antagonist, T-0632 [sodium (S)-1-(2-fluorophenyl)-2, 3-dihydro-3-[(3-isoquinolinylcarbonyl) amino]-6-methoxy-2-oxo-1H-indole-3-propanoate], on caerulein-induced and pancreatic duct ligation-induced pancreatitis models were studied and compared with the CCKA-receptor antagonist loxiglumide and the orally active protease inhibitor camostate, respectively. In rats, orally administered T-0632 potently prevented the caerulein-induced increases in pancreatic digestive enzymes in plasma and suppressed the histological changes in the pancreas. The estimated ED50 values of T-0632 and loxiglumide were 0.0092 and 8.9 mg/kg, respectively. In dogs, T-0632 (0.1, 1 mg/kg, i.d.) prevented the caerulein-induced increase in plasma amylase activity in a dose-dependent manner. Loxiglumide (100 mg/kg, i.d.) did not show any preventive effects. In pancreatic duct ligation (6 hr)-induced pancreatitis of the rat, T-0632 (0.001-0.1 mg/kg, p.o.) partially prevented both the increase in plasma amylase activity and the histological changes in the pancreas, whereas camostate (10, 100 mg/kg, p.o.) did not show any preventive effects. In pancreatic duct ligation (3 hr)-induced pancreatitis, caerulein injection (1 microgram/kg, s.c.) caused a further increase in plasma amylase activity, and T-0632 (0.01, 0.1 mg/kg, p.o.) dose-dependently decreased the aggravation by caerulein. We conclude that T-0632 showed preventive effects on all of these pancreatitis models by oral or intraduodenal administration. These results suggest that CCK plays an important role in progression and aggravation of acute pancreatitis, and T-0632 may have a therapeutic value in these disease states.


Asunto(s)
Gabexato/análogos & derivados , Indoles/farmacología , Pancreatitis/tratamiento farmacológico , Receptores de Colecistoquinina/antagonistas & inhibidores , Enfermedad Aguda , Amilasas/sangre , Animales , Ceruletida , Modelos Animales de Enfermedad , Perros , Ésteres , Femenino , Guanidinas/farmacología , Antagonistas de Hormonas/farmacología , Ligadura , Masculino , Conductos Pancreáticos/cirugía , Pancreatitis/inducido químicamente , Pancreatitis/etiología , Proglumida/análogos & derivados , Proglumida/farmacología , Inhibidores de Proteasas/farmacología , Ratas , Ratas Sprague-Dawley , Ratas Wistar , Receptor de Colecistoquinina A
13.
Nature ; 390(6655): 45-51, 1997 Nov 06.
Artículo en Inglés | MEDLINE | ID: mdl-9363890

RESUMEN

A new gene, termed klotho, has been identified that is involved in the suppression of several ageing phenotypes. A defect in klotho gene expression in the mouse results in a syndrome that resembles human ageing, including a short lifespan, infertility, arteriosclerosis, skin atrophy, osteoporosis and emphysema. The gene encodes a membrane protein that shares sequence similarity with the beta-glucosidase enzymes. The klotho gene product may function as part of a signalling pathway that regulates ageing in vivo and morbidity in age-related diseases.


Asunto(s)
Envejecimiento/genética , Proteínas de la Membrana/genética , Envejecimiento/patología , Secuencia de Aminoácidos , Animales , Arteriosclerosis/genética , Arteriosclerosis/patología , Atrofia , Calcinosis/genética , Calcinosis/patología , Clonación Molecular , Enfisema/genética , Femenino , Genitales/patología , Humanos , Masculino , Proteínas de la Membrana/fisiología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C3H , Ratones Endogámicos C57BL , Ratones Transgénicos , Datos de Secuencia Molecular , Mutagénesis Insercional , Osteoporosis/genética , Osteoporosis/patología , Fenotipo , Hipófisis/patología , Homología de Secuencia de Aminoácido , Piel/patología , Síndrome , Timo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA